First Time Loading...
J

JCR Pharmaceuticals Co Ltd
TSE:4552

Watchlist Manager
JCR Pharmaceuticals Co Ltd
TSE:4552
Watchlist
Price: 797 JPY 0.5% Market Closed
Updated: Apr 29, 2024

JCR Pharmaceuticals Co Ltd
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

JCR Pharmaceuticals Co Ltd
Net Income (Common) Peer Comparison

Comparables:
4502
4568
4578
4519
4503

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
J
JCR Pharmaceuticals Co Ltd
TSE:4552
Net Income (Common)
¥5.4B
CAGR 3-Years
9%
CAGR 5-Years
17%
CAGR 10-Years
13%
Takeda Pharmaceutical Co Ltd
TSE:4502
Net Income (Common)
¥178.2B
CAGR 3-Years
0%
CAGR 5-Years
10%
CAGR 10-Years
2%
Daiichi Sankyo Co Ltd
TSE:4568
Net Income (Common)
¥186.1B
CAGR 3-Years
38%
CAGR 5-Years
23%
CAGR 10-Years
5%
Otsuka Holdings Co Ltd
TSE:4578
Net Income (Common)
¥121.6B
CAGR 3-Years
-6%
CAGR 5-Years
8%
CAGR 10-Years
-4%
Chugai Pharmaceutical Co Ltd
TSE:4519
Net Income (Common)
¥325.5B
CAGR 3-Years
15%
CAGR 5-Years
29%
CAGR 10-Years
20%
Astellas Pharma Inc
TSE:4503
Net Income (Common)
¥37.3B
CAGR 3-Years
-35%
CAGR 5-Years
-29%
CAGR 10-Years
-9%

See Also

What is JCR Pharmaceuticals Co Ltd's Net Income (Common)?
Net Income (Common)
5.4B JPY

Based on the financial report for Dec 31, 2023, JCR Pharmaceuticals Co Ltd's Net Income (Common) amounts to 5.4B JPY.

What is JCR Pharmaceuticals Co Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
13%

Over the last year, the Net Income (Common) growth was 4%. The average annual Net Income (Common) growth rates for JCR Pharmaceuticals Co Ltd have been 9% over the past three years , 17% over the past five years , and 13% over the past ten years .